Dr. Amselem holds Ph.D. in Pharmaceutical Sciences and Pharmacology from the School of Pharmacy, Hebrew University of Jerusalem. His post doctoral studies he completed at the Walter Reed Army Institute of Research, Washington DC. Dr. Amselem served key positions in several international pharmaceutical companies including Nova Pharmaceutical Corp., Baltimore, MD; Abello SA, Madrid, Spain. Dr. Amselem successfully led pharmaceutical development of 10 new products. Six of them are marketed in the US and Europe. Prior to joining Nextar, he served for several years as Vice President of Pharmaceutical Development at Pharmos Corp. a biopharmaceutical company engaged in drug discovery and development of new chemical entities. During the last 3 years, Dr. Amselem was Chairman of the Steering Committee and Head of Bioavailability project of Pharmalogica, a consortium established by the Office of Chief Scientist of the Israeli Ministry of Industry & Trade.. He was in charge of the entire drug development processes and all CMC and DMPK activities, including synthesis of active pharmaceutical ingredients (APIs), formulation development, biopharmaceutics, bioavailability, bioanalytics, toxicity, pharmacokinetics, metabolism, GMP manufacturing of API and final dosage forms, and production of clinical trial material for human studies. In the course of his work, Dr. Amselem developed a strong network of contacts in the local and the international pharmaceutical industries

Dr. Orna Dreazen holds a Ph.D in Biochemistry from the Weizmann Institute of Science. Her postdoctoral studies were completed at University of California in Los Angeles. In 1994 she got a diploma in Business administration from the Tel Aviv University. Dreazen served in key positions in the Industry as well as a public servant: She was the Quality control manager of Interpharm Laboratories Ltd., Established a start up biotech company, Portaman pharmaceuticals Ltd. Between 1994 and 2000, she was the General Director of the National Public Health Laboratories of the Ministry of Health and between 2000 to 2008 she served as the General director of the Israel Laboratory Accreditation Authority. In this capacity, she was involved in many international activities like taking an active role as a member in the Board of Director of the International Laboratory Accreditation Cooperation (ILAC), The Arrangement Committee Chairperson, representing ILAC in ISO and WHO, and The Bureau International Poids and Measures (BIPM) managing the metrology, weights and measures around the world. Dr. Dreazen is an expert in Quality and Metrology and is the Chairperson of the Israel Society of Metrology.